Home

For Patients

The Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. (MP) is a treatment for chronic inflammatory diseases. The MPKB is a place to get answers to many of the questions patients have about the Marshall Protocol and the science which supports it. Learn about:

Marshall's theory of chronic inflammatory disease
Introduction to the MP – Length, Cost, Patient Interviews
Suitability of the MP – Therapeutic probe, Vitamin D Metabolite Calculator
Getting Started – Checklist, Finding a physician, Working with a physician
Doing the MP – Light restriction?, Food & drink, Immunopathology, Managing immunopathology, Phase One Guidelines, Non-MP treatments
Glossary of terms

For Physicians

The MP is based on the hypothesis that chronic diseases (termed Th1 illnesses), are the result of infection by an intraphagocytic, metagenomic microbiotaThe community of bacterial pathogens including those in an intracellular and biofilm state which cause chronic disease. of chronic bacterial forms that are often referred to as the Th1 pathogens.

Resources for physicians
The Marshall Pathogenesis
About immunopathology a.k.a. the Jarisch-Herxheimer reaction
Safety of the Protocol – olmesartan (Benicar), antibiotics
Guidelines – Phase One, Phase Two/Three
Physicians' concerns
Notice for emergency

Publications/Presentations

Presentation by Amy Proal – Metagenomic symbiosis between bacterial and viral pathogens in autoimmune disease
Presentation by Greg Blaney, MD – Olmesartan medoxomil and treatment of autoimmune disease
Presentation by Trevor Marshall, PhD – Olmesartan overcomes antibiotic resistance, inducing recovery from advanced autoimmune disease
Complete list

News

May 2010 – Trevor Marshall, PhD interviewed in COSMOS magazine article, Can you catch a heart attack?

About Autoimmunity Research Foundation and the MPKB Project

Autoimmunity Research Foundation is a California-based 501©3 (tax deductible) non-profit formed to educate the public about the nature of, and study a treatment for, chronic inflammatory disease. The MPKB currently contains about 400 pages and draws from the best possible evidence to support its mission. As of November 2009, about 70% of those articles are complete with the remainder scheduled to be completed in the next year.

Outline of Content (formerly on the home page)
Project Status
Tips for using this resource
History and timeline of the Autoimmunity Research Foundation

Last modified: 06.12.2010